Zobrazeno 1 - 10
of 2 933
pro vyhledávání: '"Van Os R"'
Autor:
Doppenberg, D., Besselink, M. G., van Eijck, C. H. J., Intven, M. P. W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W. M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J. M. E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., Bruynzeel, A. M. E.
Publikováno v:
BMC Cancer, 22(1):1363. BioMed Central Ltd.
BMC Cancer, 22(1):1363. BioMed Central
BMC cancer, 22(1):1363. BioMed Central
Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Koerkamp, B G, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J & Bruynzeel, A M E 2022, ' Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR) : a nationwide multicenter randomized controlled trial according to a TwiCs design ', BMC Cancer, vol. 22, no. 1, 1363 . https://doi.org/10.1186/s12885-022-10419-4
BMC Cancer, 22(1):1363. BioMed Central
BMC cancer, 22(1):1363. BioMed Central
Doppenberg, D, Besselink, M G, van Eijck, C H J, Intven, M P W, Koerkamp, B G, Kazemier, G, van Laarhoven, H W M, Meijerink, M, Molenaar, I Q, Nuyttens, J J M E, van Os, R, van Santvoort, H C, van Tienhoven, G, Verkooijen, H M, Versteijne, E, Wilmink, J W, Lagerwaard, F J & Bruynzeel, A M E 2022, ' Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR) : a nationwide multicenter randomized controlled trial according to a TwiCs design ', BMC Cancer, vol. 22, no. 1, 1363 . https://doi.org/10.1186/s12885-022-10419-4
Background Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic) pancreatic ductal adenocarcinoma (PDAC). These patients are currently treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5169fadd7fb4a9bc8627136192b56e04
https://pure.eur.nl/en/publications/c0fa240a-9604-4b7c-9295-9301cd36830b
https://pure.eur.nl/en/publications/c0fa240a-9604-4b7c-9295-9301cd36830b
Autor:
Dieleman E; Amsterdam UMC location AMC, Radiation Oncology, Amsterdam, The Netherlands., van der Woude L; RadboudUMC, Cardiothoracic surgery, Nijmegen, The Netherlands; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., van Os R; Amsterdam UMC location AMC, Radiation Oncology, Amsterdam, The Netherlands., van Bockel L; Haga ziekenhuis, Radiation Oncology, Den Haag, The Netherlands., Coremans I; LUMC, Radiation Oncology, Leiden, The Netherlands., van Es C; UMCU, Radiation Oncology, Utrecht, The Netherlands., De Jaeger K; Catharina Ziekenhuis, Radiation Oncology, Eindhoven, The Netherlands., Knol HP; Noordwest Ziekenhuis groep, Radiation Oncology, Alkmaar, The Netherlands., Kolff W; Amsterdam UMC location AMC, Radiation Oncology, Amsterdam, The Netherlands., Koppe F; Instituut Verbeeten, Radiation Oncology, Tilburg, The Netherlands., Pomp J; Medisch Spectrum Twente, Radiation Oncology, Enschede, The Netherlands., Reymen B; Maastro, Radiation Oncology, Maastricht, The Netherlands., Schinagl D; RadboudUMC, Radiation Oncology, Nijmegen, The Netherlands., Spoelstra F; Amsterdam UMC location VUMC, Radiation Oncology, Amsterdam, The Netherlands., Tissing-Tan C; Radiotherapiegroep, Radiation Oncology, Arnhem, The Netherlands., van der Voort van Zyp N; Haaglanden MC, Radiation oncology, Den Haag, The Netherlands., van der Wel A; Radiotherapeutisch Instituut Friesland, Radiation Oncology, Leeuwarden, The Netherlands., Wijsman R; UMCG, Radiation Oncology, Groningen, The Netherlands., Dielwart M; ZRTI, Radiation Oncology, Vlissingen, The Netherlands., Wiegman E; Isala, Radiation Oncology, Zwolle, The Netherlands., Damhuis R; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Belderbos J; Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2023 Mar; Vol. 24 (2), pp. 130-136. Date of Electronic Publication: 2022 Nov 25.
Autor:
Doppenberg D; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Besselink MG; Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Intven MPW; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kazemier G; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, The Netherlands., van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands., Meijerink M; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Intervention Radiology, Amsterdam, The Netherlands., Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Nuyttens JJME; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Os R; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands., van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands., van Tienhoven G; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Verkooijen HM; Department of Surgery, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Versteijne E; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Wilmink JW; Cancer Center Amsterdam, Amsterdam, The Netherlands.; Amsterdam UMC, Location University of Amsterdam, Department of Medical Oncology, Amsterdam, The Netherlands., Lagerwaard FJ; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands., Bruynzeel AME; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Radiation Oncology, Amsterdam, The Netherlands. ame.bruynzeel@amsterdamUMC.nl.; Cancer Center Amsterdam, Amsterdam, The Netherlands. ame.bruynzeel@amsterdamUMC.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Jan 20; Vol. 23 (1), pp. 70. Date of Electronic Publication: 2023 Jan 20.
Autor:
Serrano Martinez P; Department of Biomedical Sciences of Cells and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands., Maimets M; Department of Biomedical Sciences of Cells and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands., Bron R; Department of Biomedical Sciences of Cells and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands.; Department of Biomedical Engineering, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands., van Os R; Department of Biology of Aging, Section Stem Cell Biology, European Research Institute for the Biology of Aging (ERIBA), University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands., de Haan G; Department of Biology of Aging, Section Stem Cell Biology, European Research Institute for the Biology of Aging (ERIBA), University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands., Pringle S; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, the Netherlands., Coppes RP; Department of Biomedical Sciences of Cells and Systems, Section Molecular Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands.
Publikováno v:
IScience [iScience] 2022 Sep 02; Vol. 25 (10), pp. 105047. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).
Autor:
Schouten D; Department of Radiotherapy, Amsterdam University Medical Centre, Amsterdam, The Netherlands., van Os R; Department of Radiotherapy, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Westermann AM; Medical Oncology, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Crezee H; Department of Radiotherapy, Amsterdam University Medical Centre, Amsterdam, The Netherlands., van Tienhoven G; Department of Radiotherapy, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Kolff MW; Department of Radiotherapy, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Bins AD; Medical Oncology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Apr; Vol. 61 (4), pp. 441-448. Date of Electronic Publication: 2022 Feb 09.
Autor:
Bellantuono, I., DeCabo, R., Ehninger, D., Fernandes, A., Howlett, S.E., Müller, R., Potter, P., Tchkonia, T., Trendelenburg, A.-U., Trejo, J.L., Vandenbroucke, R., van Os, R., van Riel, N.A.W.
Publikováno v:
Nature, 554(7692), 293-295. Nature Publishing Group
Simply extending lifespan is not enough. We need treatments that boost resilience to multiple age-related diseases, argue Ilaria Bellantuono and 12 co-signatories. Simply extending lifespan is not enough. We need treatments that boost resilience to m
Autor:
Butcher MC; Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgowgrid.8756.c, Glasgow, UK., Brown JL; Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgowgrid.8756.c, Glasgow, UK., Hansom D; Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgowgrid.8756.c, Glasgow, UK.; Forth Valley Royal Hospital, Larbert, UK., Wilson-Van Os R; Biocomposites Ltd., Keele, Staffordshire, UK., Delury C; Biocomposites Ltd., Keele, Staffordshire, UK., Laycock PA; Biocomposites Ltd., Keele, Staffordshire, UK., Ramage G; Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgowgrid.8756.c, Glasgow, UK.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jan 18; Vol. 66 (1), pp. e0171321. Date of Electronic Publication: 2021 Oct 25.
Publikováno v:
Population Space and Place, 23(8):e2059. John Wiley & Sons Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c1875616e0edaff96328ee6e18771b88
https://pure.eur.nl/en/publications/88a3d621-84eb-45c5-8d3c-b4a14f164e85
https://pure.eur.nl/en/publications/88a3d621-84eb-45c5-8d3c-b4a14f164e85
Autor:
Rocchi C; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Cinat D; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Serrano Martinez P; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Bruin ALJ; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Baanstra M; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Brouwer U; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Del Angel Zuivre C; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands., Schepers H; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands., van Os R; European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands., Barazzuol L; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Coppes RP; Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen 9713 AV, Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.
Publikováno v:
Science signaling [Sci Signal] 2021 Dec 07; Vol. 14 (712), pp. eabk0599. Date of Electronic Publication: 2021 Dec 07.
Autor:
Versteijne, Eva, van Laarhoven, H. W.M., van Hooft, J. E., van Os, R. M., Geijsen, E. D., van Berge Henegouwen, M. I., Hulshof, M. C.C.M.
Publikováno v:
Versteijne, E, van Laarhoven, H W M, van Hooft, J E, van Os, R M, Geijsen, E D, van Berge Henegouwen, M I & Hulshof, M C C M 2015, ' Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer : locoregional recurrence pattern ', Diseases of the Esophagus, vol. 28, no. 5, pp. 453-459 . https://doi.org/10.1111/dote.12215
Diseases of the esophagus, 28(5), 453-459. Wiley-Blackwell
Diseases of the Esophagus, 28(5), 453-459. Wiley-Blackwell
Diseases of the esophagus, 28(5), 453-459. Wiley-Blackwell
Diseases of the Esophagus, 28(5), 453-459. Wiley-Blackwell
A locoregional recurrence after definitive chemoradiation (dCRT) for patients with inoperable or unresectable esophageal cancer occurs in about 50% of the patients and is a major cause of failure with a poor prognosis. The aim of this study was to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dbca41fef045fcf7ff0f5da466492ba3
https://research.vumc.nl/en/publications/40fccb67-4061-4951-b205-c74a8a4585d2
https://research.vumc.nl/en/publications/40fccb67-4061-4951-b205-c74a8a4585d2